Dana-Farber/Brigham and Women’s Cancer Center (DF/BWCC) offers medical professionals a variety of resources to help you explain the importance of precision cancer medicine and targeted therapies to your patients. These resources are provided to support the best possible care for your patients. We welcome the opportunity to collaborate with you.
In this video, Dana-Farber’s President and CEO Edward J. Benz, Jr., MD, provides a perspective on precision cancer medicine in his talk “Enterprise-wide Support for Individualized Treatment at a Cancer Center: Lessons Learned From DF/BW/BCHCC’s Profile Project.”
DF/BWCC offers post-graduate courses for community providers to keep you abreast of the latest developments in clinical research and treatment. These courses are offered in conjunction with the Harvard Medical School Department of Continuing Medical Education, which is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
DF/BWCC is dedicated to physician education to improve cancer care for all. In these videos, our surgical oncology team shares advances in surgical techniques that improve patient outcomes and recovery.
Receive quarterly updates about Dana-Farber’s advances in cancer research and care, current clinical trials, and upcoming CME programs.
Keep abreast of ongoing cancer research with these progress reports published in leading scientific journals.
The Center for Clinical Investigation offers educational programs designed to promote high quality clinical research.